Skip to content
Open access

Disorders of vitamin B9 and B12 metabolism in children: prevalence, selected clinical aspects, and optimization of diagnostic approaches

Sep 2026 · Medičnì Perspektivi · 0 citations

Abstract

Disorders of vitamin B9 and B12 metabolism is an important problem in modern pediatrics due to its prevalence, nonspecific clinical manifestations, and diagnostic difficulties. Aim – to evaluate the prevalence and features of vitamin B9 and B12 metabolic disorders in school-aged children, to assess the role of hyper­homocysteinemia in clinical manifestations, and to improve diagnostic approaches. We analyzed 100 scientific publications (70% PubMed and Google Scholar) and examined 84 children aged 6-16 years observed at Ivano-Frankivsk Regional Children’s Clinical Hospital (59.5%) and the medical center “Doctor Tsaruk” (40.5%) during 2023-2026. Serum concen­trations of vitamins B9 and B12 were determined using enzyme-linked immunosorbent assay, plasma homocysteine con­centration was measured by high-performance liquid chromatography, and MTHFR C677T and MTRR A66G polymor­phisms were analyzed using polymerase chain reaction. Cognitive status was assessed using a Likert-scale questionnaire developed by the authors. Vitamin B12 and B9 deficiency in Ukraine ranges from 13.5-18.9%. The main clinical features were fatigue (85.7%) and weakness (77.4%). Cognitive disorders were significantly more frequent in children aged 6-12 years than in adolescents (93.1% vs 25.0%; χ²=34.8; p<0.0001). Adolescents more often reported memory impairment (54.5%) and reduced attention (45.4%). Isolated vitamin B12 deficiency was found in 54.8% of children, vitamin B9 deficiency – in 29.7%, and combined deficiency – in 13%. Mean corpuscular volume was higher in the combined deficiency group (104.8±7.1 fL), indicating macrocytic changes. Methylmalonic acid levels were increased in B12-deficient and combi­ned groups. The MTHFR C677T homozygous variant was associated with higher homocysteine levels (r=0.64; p<0.0. Chil­dren with combined deficiency showed significantly worse cognitive perfor­mance than those with isolated deficiency (p<0.05). Thus, Vitamin B9 and B12 deficiency is an important risk factor for cognitive impairment in children. Combined deficiency has a more severe clinical impact which underscores the need for early diagnosis and the consideration of genetic factors. A pathogenetically grounded approach makes it possible to improve treatment outcomes and the prevention of neurological complications.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.